Literature DB >> 31147924

Purification and Biophysical Characterization of the Mre11-Rad50-Nbs1 Complex.

Logan R Myler1, Michael M Soniat1,2, Xiaoming Zhang1,3, Rajashree A Deshpande1,3, Tanya T Paull1,3, Ilya J Finkelstein4,5.   

Abstract

The Mre11-Rad50-Nbs1 (MRN) complex coordinates the repair of DNA double-strand breaks, replication fork restart, meiosis, class-switch recombination, and telomere maintenance. As such, MRN is an essential molecular machine that has homologs in all organisms of life, from bacteriophage to humans. In human cells, MRN is a >500 kDa multifunctional complex that encodes DNA binding, ATPase, and both endonuclease and exonuclease activities. MRN also forms larger assemblies and interacts with multiple DNA repair and replication factors. The enzymatic properties of MRN have been the subject of intense research for over 20 years, and more recently, single-molecule biophysics studies are beginning to probe its many biochemical activities. Here, we describe the methods used to overexpress, fluorescently label, and visualize MRN and its activities on single molecules of DNA.

Entities:  

Keywords:  DNA curtains; DNA repair; Homologous recombination; MRN; Single-molecule imaging

Year:  2019        PMID: 31147924      PMCID: PMC6667175          DOI: 10.1007/978-1-4939-9520-2_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  45 in total

1.  Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex.

Authors:  T T Paull; M Gellert
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

2.  Purification and biochemical characterization of ataxia-telangiectasia mutated and Mre11/Rad50/Nbs1.

Authors:  Ji-Hoon Lee; Tanya T Paull
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 3.  The role of double-strand break repair pathways at functional and dysfunctional telomeres.

Authors:  Ylli Doksani; Titia de Lange
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-09-16       Impact factor: 10.005

Review 4.  Targeting DNA Repair in Cancer: Beyond PARP Inhibitors.

Authors:  Jessica S Brown; Brent O'Carrigan; Stephen P Jackson; Timothy A Yap
Journal:  Cancer Discov       Date:  2016-12-21       Impact factor: 39.397

Review 5.  Mechanism and regulation of meiotic recombination initiation.

Authors:  Isabel Lam; Scott Keeney
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-16       Impact factor: 10.005

6.  Interdependence of the rad50 hook and globular domain functions.

Authors:  Marcel Hohl; Tomasz Kochańczyk; Cristina Tous; Andrés Aguilera; Artur Krężel; John H J Petrini
Journal:  Mol Cell       Date:  2015-01-15       Impact factor: 17.970

7.  Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer.

Authors:  Michael M Vilenchik; Alfred G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

8.  ATP driven structural changes of the bacterial Mre11:Rad50 catalytic head complex.

Authors:  Carolin Möckel; Katja Lammens; Alexandra Schele; Karl-Peter Hopfner
Journal:  Nucleic Acids Res       Date:  2011-09-21       Impact factor: 16.971

9.  The structure of ends determines the pathway choice and Mre11 nuclease dependency of DNA double-strand break repair.

Authors:  Shuren Liao; Margaret Tammaro; Hong Yan
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

10.  Rad50 ATPase activity is regulated by DNA ends and requires coordination of both active sites.

Authors:  Rajashree A Deshpande; Ji-Hoon Lee; Tanya T Paull
Journal:  Nucleic Acids Res       Date:  2017-05-19       Impact factor: 16.971

View more
  1 in total

1.  ATM and PRDM9 regulate SPO11-bound recombination intermediates during meiosis.

Authors:  Jacob Paiano; Wei Wu; Shintaro Yamada; Nicholas Sciascia; Elsa Callen; Ana Paola Cotrim; Rajashree A Deshpande; Yaakov Maman; Amanda Day; Tanya T Paull; André Nussenzweig
Journal:  Nat Commun       Date:  2020-02-12       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.